
Avience Biomedicals Ltd
IPO Day 1 Subscription Status

June 18, 2026 | 2 min read
Avience Biomedicals Ltd IPO Day 1 Subscriptions details: check bidding details
Avience Biomedicals Ltd IPO day 1 subscription details:
The initial public offering of Avience Biomedicals Ltd ended the first day with investors bidding 3.79 the available shares on offer worth 30.24. The retail investor portion of the IPO was subscribed 6.21 times the available shares on offer. Retail investors have 46.09% of the total issue reserved for them.
At the end of bidding on day 1, the qualified institutional buyers' (QIB) portion of the 0.00% got bids for 0.0 times the available shares on offer. The QIB portion includes insurance companies, domestic mutual funds, foreign institutional buyers, and other institutional investors.
The non-institutional investors quota got bids for 3.36 times the available quota of shares. This segment includes HNI and ultra HNI investors.
Here's a snapshot of the subscription details:
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutional Buyers (QIB) | 0.0 |
| Non-Institutional Investors (NII) | 3.36 |
| Retail Individual Investors (RII) | 6.21 |
| Total | 9.57 |
Avience Biomedicals Ltd IPO details :
Avience Biomedicals Ltd's IPO consists of a fresh issue of ₹30.24. The IPO’s price band is ₹196 – ₹208 per share. The company’s shares will be listed on NSE - SME on 25 Jun 26.
Here are the key details of Avience Biomedicals Ltd IPO
Offer for sale: 0.00 shares
Fresh issue: 30.24
Price Band: ₹196 – ₹208 per share
Bid open dates: 18 Jun 26
Allotment date: 23 Jun 26
Listing date: 25 Jun 26
